Lakeland Regional Medical Center

(863) 687-1100

Lakeland Regional Cancer Center
Lakeland Regional Cancer Center
Lakeland Regional Cancer Center

Print Page

Head and Neck

Clinical Trial A091101:

  • Locally or regionally advance squamous cell carcinoma.   Patients with  Stage III hypopharynx or Stage IV a-b squamous cell carcinoma (other than oropharyngeal) or Stage IV a-b HPV negative oropharyngeal may be eligible.  Participants will be treated with Taxotere/Cisplatin and ABT888 followed by Cisplatin and Radiation Therapy.  Participants must have measurable disease and be able to swallow. 
  • Exclusions include, but are not limited to:  Seizure disorders, impaired gastrointestinal function, HIV (currently on antiviral cocktail), chronic systemic steroid use and unstable angina, cardiac arrhythmia or infection.


Clinical TrialGT-001:

  • Use of IV GC4419 with chemotherapy and radiation for mucositis prevention. 
  • Inclusions include patients with Squamous Cell Carcinoma of the oral cavity or oropharynx who will be starting chemotherapy and radiation with IMRT between 2.0-2.2 Gy per day.
  • Exclusions include, but are not limited to, tumors of the lips, larynx, hypopharynx, sinuses, salivary glands or an unknown primary, Stage IV C disease, active infection/oral mucositis and HIV or Hep B or C.

© 2015 Lakeland Regional Medical Center